|
| |
| | | | 1 | | | DO1.PCCNTR.1041635 ContractData Container |
| | | 1.1 | | | | | | | | | | 7,469,848.50 | 0.00 | 0.00 | 0.00 | 5,429,555.00 | 7,469,848.50 |
|
| | | | | | | 1 | | 2.3.4.1.01 | BEVACIZUMAB 100 MG INY (AVASTIN) | 25 | UD | 24,800 | 28,690 | 717,250.00 | | 0.00 | | | 0.00 | | 0.00 | 620,000.00 | 717,250.00 | |
|
| | | | | | | 2 | | 2.3.4.1.01 | BEVACIZUMAB 400 MG INY (AVASTIN) | 20 | UD | 97,827 | 114,758 | 2,295,160.00 | | 0.00 | | | 0.00 | | 0.00 | 1,956,540.00 | 2,295,160.00 | |
|
| | | | | | | 3 | | 2.3.4.1.01 | CAPECITABINA 500 MG TABLETA (XELODA) | 3,000 | UD | 174 | 180 | 540,000.00 | | 0.00 | | | 0.00 | | 0.00 | 522,000.00 | 540,000.00 | |
|
| | | | | | | 4 | | 2.3.4.1.01 | CETUXIMAB 5 MG / 20 ML AMP (ERBITUX) | 30 | UD | 27,000 | 30,215 | 906,450.00 | | 0.00 | | | 0.00 | | 0.00 | 810,000.00 | 906,450.00 | |
|
| | | | | | | 5 | | 51151506 - Inhibidor de l(...)51151506 - Inhibidor de la esterasa |
| 2.3.4.1.01 | ERLOTINIB 150 MG COMP. (TARCEVA) | 15 | UD | 4,710 | 5,310.7 | 79,660.50 | | 0.00 | | | 0.00 | | 0.00 | 70,650.00 | 79,660.50 | |
|
| | | | | | | 6 | | 2.3.4.1.01 | PERTUZUMAB 420 MG (PERJETA) | 3 | UD | 47,485 | 246,452 | 739,356.00 | | 0.00 | | | 0.00 | | 0.00 | 142,455.00 | 739,356.00 | |
|
| | | | | | | 7 | | 2.3.4.1.01 | RITUXIMAB 1,400 MG / 11.7 ML INY (MABTHERA) | 7 | UD | 78,000 | 78,400 | 548,800.00 | | 0.00 | | | 0.00 | | 0.00 | 546,000.00 | 548,800.00 | |
|
| | | | | | | 8 | | 2.3.4.1.01 | RITUXIMAB 500 MG INY (MABTHERA) | 10 | UD | 67,200 | 67,200 | 672,000.00 | | 0.00 | | | 0.00 | | 0.00 | 672,000.00 | 672,000.00 | |
|
| | | | | | | 9 | | 2.3.4.1.01 | TRASTUZUMAB 600 MG / 5 ML VIAL (HERCEPTIN) | 9 | UD | 9,990 | 107,908 | 971,172.00 | | 0.00 | | | 0.00 | | 0.00 | 89,910.00 | 971,172.00 | |
|
|
| | | |
| | | |
|